small molecule

LONSURF

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

Loss of exclusivityFebruary 2037latest FDA-listed patent expiry

CompanyTaiho Oncology →View the full company profile on CliffBio

Drug detail

Brand name	LONSURF
Active ingredient	TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE
Strength	EQ 6.14MG BASE;15MG
Dosage form	TABLET
Route	ORAL
Modality	Small molecule
FDA approval	September 2015
Marketing status	RX

Listed patents

Patent	Expires	Type
10456399	February 2037	use U-3658
10960004	February 2037	use U-3658
9943537	September 2034	use U-3659
9527833	June 2034	substance, product
10457666	June 2034	substance, product
RE46284	September 2029	use U-3656

Regulatory exclusivity

Code	Expires
ODE-229	February 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from Taiho Oncology